Close Menu

hereditary cancer

NEW YORK (GenomeWeb News) – A new study suggests gene panels can pick up potentially pathogenic variants in hereditary, cancer-related genes in a clinical setting — in some cases leading to more aggressive screening and detection strategies.

Researchers in the department of genetics at The Netherlands' University of Groningen are working to develop targeted next-generation sequencing panels to replace the Sanger sequencing that has previously been the group's standard in several disease areas.

NEW YORK (GenomeWeb News) – Myriad Genetics will adopt RainDance Technologies' microdroplet PCR-based target enrichment technology for use in a next-generation sequencing-based hereditary cancer panel test that Myriad is currently developing, the companies said today.

In preparation for the launch, the laboratory is currently exploring the test in a clinical research setting and is hoping to sequence its first genome next month.

During Myriad's investor day last week, officials disclosed that the firm is working with pharmaceutical companies to develop companion diagnostics for PARP inhibitors and PTEN inhibitors.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.